Costs and cost-effectiveness of a collaborative data-to-care intervention for HIV treatment and care in the United States

被引:1
|
作者
Shrestha, Ram K. [1 ,2 ]
Fanfair, Robyn Neblett [2 ]
Randall, Liisa M. [3 ]
Lucas, Crystal [4 ]
Nichols, Lisa [5 ]
Camp, Nasima [2 ]
Brady, Kathleen A. [4 ]
Jenkins, Heidi [6 ]
Altice, Frederick L. [5 ]
DeMaria, Alfred [3 ]
Villanueva, Merceditas [5 ]
Weidle, Paul J. [2 ]
机构
[1] Ctr Dis Control & Prevent, Div HIV Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, 1600 Clifton Rd MS E 45, Atlanta, GA 30329 USA
[2] Ctr Dis Control & Prevent, Div HIV Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Atlanta, GA USA
[3] Massachusetts Dept Publ Hlth, Boston, MA USA
[4] Philadelphia Dept Publ Hlth, Philadelphia, PA USA
[5] Yale Univ, Sch Med, New Haven, CT USA
[6] Connecticut Dept Publ Hlth, Hartford, CT USA
关键词
HIV surveillance; data-to-care; re-engagement; randomized controlled trial; economic evaluation; cost-effectiveness;
D O I
10.1002/jia2.26040
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IntroductionData-to-care programmes utilize surveillance data to identify persons who are out of HIV care, re-engage them in care and improve HIV care outcomes. We assess the costs and cost-effectiveness of re-engagement in an HIV care intervention in the United States. MethodsThe Cooperative Re-engagement Control Trial (CoRECT) employed a data-to-care collaborative model between health departments and HIV care providers, August 2016-July 2018. The health departments in Connecticut (CT), Massachusetts (MA) and Philadelphia (PHL) collaborated with HIV clinics to identify newly out-of-care patients and randomize them to receive usual linkage and engagement in care services (standard-of-care control arm) or health department-initiated active re-engagement services (intervention arm). We used a microcosting approach to identify the activities and resources involved in the CoRECT intervention, separate from the standard-of-care, and quantified the costs. The cost data were collected at the start-up and recurrent phases of the trial to incorporate potential variation in the intervention costs. The costs were estimated from the healthcare provider perspective. ResultsThe CoRECT trial in CT, MA and PHL randomly assigned on average 327, 316 and 305 participants per year either to the intervention arm (n = 166, 159 and 155) or the standard-of-care arm (n = 161, 157 and 150), respectively. Of those randomized, the number of participants re-engaged in care within 90 days in the intervention and standard-of-care arms was 85 and 70 in CT, 84 and 70 in MA, and 98 and 67 in PHL. The additional number of participants re-engaged in care in the intervention arm compared with those in the standard-of-care arm was 15 (CT), 14 (MA) and 31 (PHL). We estimated the annual total cost of the CoRECT intervention at $490,040 in CT, $473,297 in MA and $439,237 in PHL. The average cost per participant enrolled was $2952, $2977 and $2834 and the average cost per participant re-engaged in care was $5765, $5634 and $4482. We estimated an incremental cost per participant re-engaged in care at $32,669 (CT), $33,807 (MA) and $14,169 (PHL). ConclusionsThe costs of the CoRECT intervention that identified newly out-of-care patients and re-engaged them in HIV care are comparable with other similar interventions, suggesting a potential for its cost-effectiveness in the US context.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Cost-Effectiveness of Collaborative Care for Depression in HIV Clinics
    Painter, Jacob T.
    Fortney, John C.
    Gifford, Allen L.
    Rimland, David
    Monson, Thomas
    Rodriguez-Barradas, Maria C.
    Pyne, Jeffrey M.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 70 (04) : 377 - 385
  • [2] Cost-Effectiveness of a Nonpharmacological Intervention in Pediatric Burn Care
    Brown, Nadia J.
    David, Michael
    Cuttle, Leila
    Kimble, Roy M.
    Rodger, Sylvia
    Higashi, Hideki
    VALUE IN HEALTH, 2015, 18 (05) : 631 - 637
  • [3] Costs and cost-effectiveness of periviable care
    Caughey, Aaron B.
    Burchfield, David J.
    SEMINARS IN PERINATOLOGY, 2014, 38 (01) : 56 - 62
  • [4] Cost-effectiveness analysis of a collaborative care programme for depression in primary care
    Aragones, Enric
    Lopez-Cortacans, German
    Sanchez-Iriso, Eduardo
    Pinol, Josep-Lluis
    Caballero, Antonia
    Salvador-Carulla, Luis
    Cabases, Juan
    JOURNAL OF AFFECTIVE DISORDERS, 2014, 159 : 85 - 93
  • [5] Cost-effectiveness Analysis of a Rural Telemedicine Collaborative Care Intervention for Depression
    Pyne, Jeffrey M.
    Fortney, John C.
    Tripathi, Shanti Prakash
    Maciejewski, Matthew L.
    Edlund, Mark J.
    Williams, D. Keith
    ARCHIVES OF GENERAL PSYCHIATRY, 2010, 67 (08) : 812 - 821
  • [6] Cost-Effectiveness of Collaborative Care for the Treatment of Depressive Disorders in Primary Care: A Systematic Review
    Grochtdreis, Thomas
    Brettschneider, Christian
    Wegener, Annemarie
    Watzke, Birgit
    Riedel-Heller, Steffi
    Haerter, Martin
    Koenig, Hans-Helmut
    PLOS ONE, 2015, 10 (05):
  • [7] The cost-effectiveness of brief intervention versus brief treatment of Screening, Brief Intervention and Referral to Treatment (SBIRT) in the United States
    Barbosa, Carolina
    Cowell, Alexander
    Dowd, William
    Landwehr, Justin
    Aldridge, Arnie
    Bray, Jeremy
    ADDICTION, 2017, 112 : 73 - 81
  • [8] The cost-effectiveness of expanded HIV screening in the United States
    Lucas, Aaron
    Armbruster, Benjamin
    AIDS, 2013, 27 (05) : 795 - 801
  • [9] Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression
    Von Korff, M
    Katon, W
    Bush, T
    Lin, EHB
    Simon, GE
    Saunders, K
    Ludman, E
    Walker, E
    Unutzer, J
    PSYCHOSOMATIC MEDICINE, 1998, 60 (02): : 143 - 149
  • [10] Cost-effectiveness of tipranavir in treatment-experienced HIV patients in the United States
    Simpson, Kit N.
    Roberts, Graeme
    Hicks, Charles B.
    Finnern, Henrik W.
    HIV CLINICAL TRIALS, 2008, 9 (04): : 225 - 237